Bandingkan Harga & Kinerja Rig Tenders Indonesia Tbk. (RIGS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Rig Tenders Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Rig Tenders Indonesia Tbk. diperdagangkan di Rp705 (kapitalisasi pasar 426,39 M, volume 24 jam 36,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Rig Tenders Indonesia Tbk. jauh lebih besar — sekitar 4,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RIGS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 426,39 M | 104,4 M |
Volume | 36,2 rb | — |
Lot | 362 | — |
Perputaran | 25,16 jt | — |
Harga Rata-rata | 695,12 | — |
Nilai Transaksi | 25,16 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Rig Tenders Indonesia Tbk.
PT Rig Tenders Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967, as amended by Law No. 11 year 1970, based on Notarial Deed of Mrs. Darwani Sidi Bakaroedin, S.H. No. 25 dated 22 January 1974, which was approved by the Minister of Justice of the Republic of Indonesia in his Decision Letter No. Y.A. 5/98/10, dated 1 April 1974, and was published in State Gazette of the Republic of Indonesia No. 39 dated 14 May 1974, Supplement No. 187/1974. PT. Rigs Tenders Indonesia provides shipping services for the offshore oil and gas industry in Indonesia waters. Supported by a fleet of 23 vessels since 1988.
Selengkapnya di halaman RIGS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
